Literature DB >> 6467169

Delay in diagnosis of cancer. Possible effects on the stage of disease and survival.

E Robinson, J Mohilever, J Zidan, D Sapir.   

Abstract

A total of 2299 new cancer patients were referred to the Northern Israel Oncology Center in 1974 and in 1980. The stage of disease, delay in diagnosis, the responsibility for the delay, and the survival of those referred in 1974 were investigated. At the time of diagnosis, 39% of the patients had localized disease, 34% had locally advanced disease, and 23% had metastatic disease. In 52% of the patients there was no delay in diagnosis. No correlation was found in the group as a whole between the stage of disease and delay in diagnosis. Only in the breast cancer group without delay in diagnosis, however, were there significantly more patients at an early stage than at an advanced stage of disease. At each stage of disease, responsibility for the delay was shared about equally between the patients and the physicians, except in advanced breast cancer, where the patients were more often responsible for the delay. The survival rate was higher in patients in whom the disease was diagnosed earlier. It was also higher at each clinical stage (Stages I and II) in patients who had no delay than in those with delay in diagnosis. The survival rate was higher in patients who were themselves responsible for the delay in diagnosis than in patients whose physicians were responsible for the delay. In 1980, less diagnosis were delayed in fewer patients than in 1974 (42% versus 65%). Responsibility for the delay in 1980 lay equally with the patients and with the physicians, but when compared to 1974, the physicians' responsibility and administrative delay were less. Campaigns for early diagnosis are advocated.

Entities:  

Mesh:

Year:  1984        PMID: 6467169     DOI: 10.1002/1097-0142(19841001)54:7<1454::aid-cncr2820540739>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Psychological factors related to delay in consultation for cancer symptoms.

Authors:  Stephen L Ristvedt; Kathryn M Trinkaus
Journal:  Psychooncology       Date:  2005-05       Impact factor: 3.894

2.  Delays in the diagnosis and surgical treatment of lung cancer.

Authors:  J S Billing; F C Wells
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

3.  Do we believe what patients say about their neoplastic symptoms? An analysis of factors that influence the interviewer's judgement.

Authors:  M Porta; N Malats; J Belloc; M Gallén; E Fernandez
Journal:  Eur J Epidemiol       Date:  1996-12       Impact factor: 8.082

4.  Time to treatment in patients with stage III non-small cell lung cancer.

Authors:  Li Wang; Candace R Correa; James A Hayman; Lujun Zhao; Kemp Cease; Dean Brenner; Doug Arenberg; Jeffery Curtis; Gregory P Kalemkerian; Feng-Ming Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-21       Impact factor: 7.038

5.  Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT.

Authors:  Jingbo Wang; Pawinee Mahasittiwat; Ka Kit Wong; Leslie E Quint; Feng-Ming Spring Kong
Journal:  Lung Cancer       Date:  2012-07-28       Impact factor: 5.705

6.  Diagnostic delay, clinical stage, and social class: a hospital based study.

Authors:  P Vineis; G Fornero; A Magnino; R Giacometti; G Ciccone
Journal:  J Epidemiol Community Health       Date:  1993-06       Impact factor: 3.710

7.  Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites.

Authors:  M Porta; M Gallén; N Malats; J Planas
Journal:  J Epidemiol Community Health       Date:  1991-09       Impact factor: 3.710

8.  Who and what influences delayed presentation in breast cancer?

Authors:  C C Burgess; A J Ramirez; M A Richards; S B Love
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

9.  Do diagnostic delays in cancer matter?

Authors:  R D Neal
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

10.  Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival.

Authors:  M Pitchers; C Martin
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.